SCHEMBL4510907

SCHEMBL4510907

[CH2]C1=CC=CN(c2sc3c(c2C#N)CCN(C(=O)OC(C)(C)C)C3)C1

nearest known ligand 0.45

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
▸ ADORA1 P30542 2/20 0.45
▸ MAPT P10636 5/20 0.44
▸ KDM4E B2RXH2 3/20 0.44
▸ GAA P10253 2/20 0.44
▸ BPTF Q12830 1/20 0.41
▸ MEN1 O00255 3/20 0.40
▸ ALDH1A1 P00352 3/20 0.40
▸ KMT2A Q03164 3/20 0.40
▸ HSD17B10 Q99714 2/20 0.40
▸ HPGD P15428 1/20 0.40
▸ ALOX15 P16050 1/20 0.40
▸ MKNK1 Q9BUB5 7/20 0.38
▸ LMNA P02545 1/20 0.37
▸ TP53 P04637 1/20 0.37
▸ TSHR P16473 1/20 0.37
▸ SMN1; SMN2 Q16637 1/20 0.37
▸ NPSR1 Q6W5P4 1/20 0.37
▸ L3MBTL1 Q9Y468 1/20 0.37
▸ P2RX3 P56373 2/20 0.37
▸ PRKCI P41743 1/20 0.36

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL17194353 0.79 ADORA1 (0.50) ADORA1MAPTKDM4EGAABPTF
SCHEMBL20922384 0.78 ADORA1 (0.55) ADORA1MAPTKDM4EGAABPTF
SCHEMBL17194169 0.77 L3MBTL1 (0.52) ADORA1MAPTKDM4EGAABPTF
SCHEMBL17194311 0.76 ADORA1 (0.55) ADORA1MAPTKDM4EGAABPTF
SCHEMBL17194176 0.76 ADORA1 (0.55) ADORA1MAPTKDM4EGAABPTF
SCHEMBL2643671 0.76 MAPT (0.73) ADORA1MAPTKDM4EGAABPTF
SCHEMBL17194374 0.75 KDM4E (0.47) ADORA1MAPTKDM4EGAABPTF
SCHEMBL17194296 0.74 ADORA1 (0.53) ADORA1MAPTKDM4EGAABPTF
SCHEMBL17194371 0.73 MAPT (0.52) ADORA1MAPTKDM4EGAABPTF
SCHEMBL13739786 0.72 MEN1 (0.55) ADORA1MAPTKDM4EGAABPTF

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-7517986-B2 Tetrahydropyridothiophenes for use in the treatment of cancer 4SC AG (DE) 2009-04-14 — — US disclosed
Send feedback